David Olayinka Kamson, M.D., Ph.D.

Headshot of David Olayinka Kamson
  • Assistant Professor of Oncology

Languages: English, Hungarian


Brain Cancer, Gliomas, Metastatic Brain Tumors, Neurology, Oncology ...read more


Skip Viragh Outpatient Cancer Center

201 N. Broadway
Baltimore, MD 21287 map
Phone: 410-955-8895



  • Assistant Professor of Oncology
  • Assistant Professor of Neurology

Departments / Divisions



  • MD; University of Pecs Medical School (2010)


  • Neurology; University of Chicago Medicine Mitchell Hospital-Hyde Park (2018)


  • Neuro-Oncology; Johns Hopkins University School of Medicine (2021)
  • Neuro-Oncology; National Institutes of Health (2021)

Board Certifications

  • American Board of Psychiatry And Neurology (Neurology) (2018)

Research & Publications

Research Summary

I have a special interest in interfacing clinical outcomes and multimodality radiographic biomarkers using automated processing methods and machine learning and integrating these into the brain metastasis clinic. I am working on the development of quantitative PK/PD imaging methods and ways to translate and incorporate these into future clinical trials. It is my mission to ensure recruitment and retention of underrepresented patient populations into clinical trials.

Selected Publications

View all on PubMed

Estephan F, Ye X, Dzaye O, Wagner-Johnston N, Swinnen L, Gladstone DE, Ambinder R, Kamson DO, Lambrecht S, Grossman SA. White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab. J Neurooncol. 2019;145(3):461– 6.

Komáromy H, Mingchen. H, Perlaki G, Orsi G, Nagy SA, Bosnyák E, Kamson DO, John F, Trauninger A, Pfund. Z. Influence of hemispheric white matter lesions and migraine characteristics on cortical thickness and volume. J Headache Pain. 2019;20(1). 

Ranjan S, Skorupan N, Ye X, Sivakumar A, Yankulina O, Kamson DO, Grossman SA, Dzaye O, Holdhoff M. Patterns of bevacizumab use in patients with glioblastoma: an online survey among experts in neuro-oncology. Neuro-Oncol Pract. 2020;7(1):52–8.

Khalafallah AM, Jimenez AE, Romo CG, Kamson DO, Kleinberg L, Weingart J, Brem H, Grossman SA, Mukherjee D. Quantifying the utility of a multidisciplinary neuro-oncology tumor board. J Neurosurg. 2020;1(aop):1–6.

Dresser L, Yuen CA, Wilmington A, Walker M, Vogel TJ, Merrell RT, Kamson DO. Estrogen hormone replacement therapy in incidental intracranial meningioma: a growth-rate analysis. Sci Rep. 2020 Oct 21;10(1):17960.

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button